How much dividend does NanoRepro pay?
Over the past 12 months, NanoRepro paid a dividend of 0.5 EUR . This corresponds to a dividend yield of about 27.78 %. For the coming 12 months, NanoRepro is expected to pay a dividend of 0.5 EUR.
NanoRepro Dividend 2024
NanoRepro Dividend
0.5 EUR
NanoRepro Dividend yield
27.78 %
Ticker
NN6.DE
ISIN
DE0006577109
WKN
657710
How much dividend does NanoRepro 2024 pay?
According to the latest status from September 2024, NanoRepro paid a total of 0.5 EUR per share in dividends within the last 12 months. With the current NanoRepro price of 1.8 EUR, this corresponds to a dividend yield of 27.78 %. A dividend is paid times per year.
| 27.78 % Dividend Yield | = |
|
Historical NanoRepro Dividends
A dividend is paid times per year. Last year, the payout months were and July.
| Paydate | Dividend |
|---|---|
| 7/16/2023 | 0.15 |
| 6/2/2022 | 0.5 |
1
Is the NanoRepro Dividend Safe?
NanoRepro has been increasing the dividend for 1 years.
Over the past 10 years, NanoRepro has increased it by an annual 0 %.
Over a five-year period, the distribution increased by 0%.
Analysts expect a Dividend Cut of -100% for the current fiscal year.
NanoRepro dividend payout ratio DE0006577109 · 657710
3 years
5 years
10 years
25 Years
Max
Payout ratio
Details
Payout ratio
ⓘWhat is Yearly Payout Ratio?
The yearly payout ratio for NanoRepro represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.
How to Interpret the Data
A lower payout ratio for NanoRepro could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.
Using the Data for Investments
Evaluate NanoRepro's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.
NanoRepro Payout Ratio History
| Date | NanoRepro Payout ratio |
|---|---|
| 2022 | -173.01 % |
| 2021 | 0 % |
| 2020 | 0 % |
| 2019 | 0 % |
| 2018 | 0 % |
| 2017 | 0 % |
| 2016 | 0 % |
| 2015 | 0 % |
| 2014 | 0 % |
| 2013 | 0 % |
| 2012 | 0 % |
| 2011 | 0 % |
| 2010 | 0 % |
| 2009 | 0 % |
| 2007 | 0 % |
| 2006 | 0 % |
| 2005 | 0 % |
| Payout ratio | |
|---|---|
| 2005 | 0 % |
| 2006 | 0 % |
| 2007 | 0 % |
| 2009 | 0 % |
| 2010 | 0 % |
| 2011 | 0 % |
| 2012 | 0 % |
| 2013 | 0 % |
| 2014 | 0 % |
| 2015 | 0 % |
| 2016 | 0 % |
| 2017 | 0 % |
| 2018 | 0 % |
| 2019 | 0 % |
| 2020 | 0 % |
| 2021 | 0 % |
| 2022 | -173.01 % |
Dividend Details
Understanding NanoRepro's Dividend Distributions
NanoRepro’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.
Year-to-Year Comparison
Examining NanoRepro's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.
Impact on Investments
NanoRepro's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.
Interpreting Dividend Fluctuations
Changes in NanoRepro’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.
NanoRepro Aktienanalyse
What does NanoRepro do?
The Nanorepro AG was founded in 1998 in Marburg an der Lahn and has since developed into a leading company in the development and production of diagnostic rapid tests and self-tests. The company has been listed on the Frankfurt Stock Exchange since 2006 and has its headquarters in the university city of Marburg. Nanorepro's business model focuses on the production and distribution of innovative, reliable, and easy-to-use self-tests for the medical field. The company concentrates on the practical application of the tests - they should be simple, fast, and user-friendly. Nanorepro's core competence lies in the design, production, and distribution of rapid tests and self-tests for the medical field. The company relies on close cooperation with other companies and research institutions to continuously improve the tests and develop new products. Nanorepro focuses on various areas, including the manufacturing of rapid tests and self-tests for the diagnosis of infectious diseases. In addition, the company also offers tests to check pregnancy status or determine ovulation. Nanorepro's range of products also includes self-tests for the early detection of diseases such as diabetes. With its wide range of products, the company is able to address a large customer base and achieve a positive market position. One key product of Nanorepro is the early pregnancy test. This product is easy to handle and allows women to quickly and safely determine if they are pregnant or not. Nanorepro also offers an ovulation test to help women determine the timing of ovulation. Another test offered by the company is the Lyme borreliosis self-test, which allows for the detection of antibodies to Lyme borreliosis. Nanorepro also offers numerous tests for diagnosing infectious diseases. These include tests that can diagnose bacterial or viral infections such as streptococcal infections or hepatitis B and C. The tests are highly accurate and reliable, enabling quick diagnosis and treatment. Another area in which Nanorepro is expanding is the development of self-tests for the early detection of cancer. For this purpose, the company works closely with scientific and research institutions to continuously improve the tests and make them even more precise and reliable. Nanorepro places a strong emphasis on quality control and safety in the production of the tests. The products are CE-certified, ensuring high quality and safety for the user. In addition, the company has been certified according to the standards of the International Quality Management System ISO 13485, guaranteeing a high standard in the production and marketing of medical devices. Overall, Nanorepro AG has established itself as a leading company in the field of rapid tests and self-tests. With its wide range of products and constant willingness to innovate, the company is able to quickly and effectively respond to the requirements of customers and partners. The company's extensive experience in the field of medical diagnostics contributes to Nanorepro being perceived as a reliable partner in medical technology. NanoRepro is one of the most popular companies on Eulerpool.com.Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The NanoRepro stock can be added to a savings plan with the following providers: ING
Frequently Asked Questions about NanoRepro stock
What is the dividend yield of NanoRepro?
The current dividend yield of NanoRepro is 27.78 %.
When does NanoRepro pay dividends?
NanoRepro pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of NanoRepro?
NanoRepro paid dividends every year for the past 1 years.
What is the dividend of NanoRepro?
For the upcoming 12 months, dividends amounting to 0.5 EUR are expected. This corresponds to a dividend yield of 27.78 %.
In which sector is NanoRepro located?
NanoRepro is assigned to the 'Health' sector.
Wann musste ich die Aktien von NanoRepro kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of NanoRepro from 6/20/2023 amounting to 0.15 EUR, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.
When did NanoRepro pay the last dividend?
The last dividend was paid out on 6/20/2023.
What was the dividend of NanoRepro in the year 2023?
In the year 2023, NanoRepro distributed 0 EUR as dividends.
In which currency does NanoRepro pay out the dividend?
The dividends of NanoRepro are distributed in EUR.
Andere Kennzahlen von NanoRepro
Our stock analysis for NanoRepro Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NanoRepro Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
